We also examined the Genomics of Drug Sensitivity in Cancer database (https://www.cancerrxgene.org/) and found the LNCaP to show the highest sensitivity to these PARPi, similar to our results and consistent with the low expression of XRCC1. The gene discussed is XRCC1; the disease is cancer.